[{"address1": "611 Gateway Boulevard", "address2": "Suite 120", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "650 484 0886", "website": "https://graphitebio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. The company offers GPH102 for the treatment of beta-thalassemia; and GPH201 for the treatment of XSCID, a life-threatening disease for multiple mutations in a single gene. It also offers GPH301, a product candidate for the treatment of Gaucher disease, a genetic disorder that results in a deficiency in the glucocerebrosidase enzyme. The company was formerly known as Integral Medicines, Inc., and changed its name to Graphite Bio, Inc. in August 2020. Graphite Bio, Inc. was incorporated in 2017 and is based in South San Francisco, California.", "fullTimeEmployees": 6, "companyOfficers": [{"maxAge": 1, "name": "Ms. Kimberlee Cobleigh Drapkin CPA", "age": 55, "title": "President, CEO, COO, Principal Executive, Financial & Accounting Officer and Director", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 553237, "exercisedValue": 0, "unexercisedValue": 556}, {"maxAge": 1, "name": "Dr. Matthew  Porteus M.D., Ph.D.", "age": 57, "title": "Academic Founder & Director", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 110000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Stephanie  Yao", "title": "Vice President of Communications & Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Christine  Garrett P.M.P., Ph.D.", "age": 52, "title": "Chief Strategy Officer", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 5, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1709251200, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 3.14, "open": 3.54, "dayLow": 3.41, "dayHigh": 4.26, "regularMarketPreviousClose": 3.14, "regularMarketOpen": 3.54, "regularMarketDayLow": 3.41, "regularMarketDayHigh": 4.26, "exDividendDate": 1710460800, "beta": 0.196, "forwardPE": -9.325, "volume": 4825424, "regularMarketVolume": 4825424, "averageVolume": 229855, "averageVolume10days": 587670, "averageDailyVolume10Day": 587670, "ask": 3.68, "bidSize": 4000, "askSize": 800, "marketCap": 217223632, "fiftyTwoWeekLow": 2.01, "fiftyTwoWeekHigh": 4.26, "fiftyDayAverage": 2.931, "twoHundredDayAverage": 2.5969, "currency": "USD", "enterpriseValue": 33326734, "floatShares": 16678473, "sharesOutstanding": 58236900, "sharesShort": 704044, "sharesShortPriorMonth": 801776, "sharesShortPreviousMonthDate": 1706659200, "dateShortInterest": 1709164800, "sharesPercentSharesOut": 0.0121, "heldPercentInsiders": 0.09179, "heldPercentInstitutions": 0.84430003, "shortRatio": 7.93, "shortPercentOfFloat": 0.0195, "impliedSharesOutstanding": 58236900, "bookValue": 3.165, "priceToBook": 1.1785151, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -124651000, "trailingEps": -2.19, "forwardEps": -0.4, "pegRatio": -0.3, "enterpriseToEbitda": -0.469, "52WeekChange": 0.49199998, "SandP52WeekChange": 0.30583346, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "GRPH", "underlyingSymbol": "GRPH", "shortName": "Graphite Bio, Inc.", "longName": "Graphite Bio, Inc.", "firstTradeDateEpochUtc": 1624627800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "0e2cca8f-1aec-3e6d-80d3-39814500dbb7", "messageBoardId": "finmb_688617627", "gmtOffSetMilliseconds": -14400000, "currentPrice": 3.73, "targetHighPrice": 7.0, "targetLowPrice": 7.0, "targetMeanPrice": 7.0, "targetMedianPrice": 7.0, "recommendationMean": 3.0, "recommendationKey": "hold", "numberOfAnalystOpinions": 1, "totalCash": 184259008, "totalCashPerShare": 3.164, "ebitda": -71041000, "totalDebt": 362000, "quickRatio": 38.411, "currentRatio": 39.196, "debtToEquity": 0.197, "returnOnAssets": -0.17989, "returnOnEquity": -0.51952, "freeCashflow": -44892000, "operatingCashflow": -90007000, "financialCurrency": "USD", "trailingPegRatio": null}]